SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-09-227864
Filing Date
2009-11-09
Accepted
2009-11-06 18:36:31
Documents
5
Period of Report
2009-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2009 d10q.htm 10-Q 2246788
2 SECTION 302 CERTIFICATION OF CEO dex311.htm EX-31.1 11420
3 SECTION 302 CERTIFICATION OF CFO dex312.htm EX-31.2 11417
4 SECTION 906 CERTIFICATION OF CEO dex321.htm EX-32.1 3387
5 SECTION 906 CERTIFICATION OF CFO dex322.htm EX-32.2 3382
  Complete submission text file 0001193125-09-227864.txt   2278460
Mailing Address
Business Address 16825 NORTHCHASE DR STE 1300 HOUSTON TX 77060 2818732674
US ONCOLOGY INC (Filer) CIK: 0000943061 (see all company filings)

IRS No.: 841213501 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26190 | Film No.: 091166135
SIC: 8093 Services-Specialty Outpatient Facilities, NEC

Mailing Address 16825 NORTHCHASE DRIVE, SUITE 1300 HOUSTON TX 77060
Business Address 16825 NORTHCHASE DRIVE, SUITE 1300 HOUSTON TX 77060 (832) 601-8766
US Oncology Holdings, Inc. (Filer) CIK: 0001333191 (see all company filings)

IRS No.: 200873619 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-126922 | Film No.: 091166134
SIC: 8060 Services-Hospitals